Eli Lilly’s stock falls after fake blue-check tweet

November 13, 2022

Eli Lilly’s stock fell millions in a single day to $14 billion, all thanks to a fake “verified” account on Elon Musk’s new Twitter payment system.

That account impersonated Eli Lilly and tweeted “insulin is free now,” implying that the pharmaceutical company’s insulin would soon be free.

Other Health care stocks such as Novo Nordisk and Sanofi also came under pressure on Friday, with Novo Nordisk shares falling 3.5% to 111.47 and Sanofi’s losing 3.4% to finish the regular session at 42.80, possibly in solidarity with Eli Lilly.

Although the account was quickly suspended, the damage had already been done, as worried shareholders confused it with reality and sold shares at a rapid pace.

Twitter’s disinformation problem is exacerbated by the democratization of the Blue Check, which has since been halted. Several corporate and government imposters targeted Eli Lilly and Company, including fake accounts for defense manufacturer Lockheed Martin, oil company BP, and produce distributor Chiquita.

The sources for this piece include an article in Investors.com.

Top Stories

Related Articles

April 8, 2026 Anthropic has signed a new agreement with Google and Broadcom to significantly expand the compute capacity powering more...

April 8, 2026 Target has updated its terms to state that customers are responsible for purchases made by its upcoming more...

April 7, 2026 OpenAI released new policy recommendations aimed at ensuring artificial intelligence benefits society as systems approach superintelligence. At more...

April 7, 2026 ChatGPT has lost market share in the U.S. mobile chatbot market for four consecutive months, dropping below more...

Jim Love

Jim is an author and podcast host with over 40 years in technology.

Share:
Facebook
Twitter
LinkedIn